These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 19764912

  • 1. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C, Martin G, Lange C, Gogaki EG, Fiedler U, Schaffner F, Hansen LL, Augustin HG, Agostini HT.
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [Abstract] [Full Text] [Related]

  • 2. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 3. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C, Filippi L, Dal Monte M, Martini D, Cammalleri M, Fortunato P, la Marca G, Fiorini P, Bagnoli P.
    Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):155-70. PubMed ID: 20739470
    [Abstract] [Full Text] [Related]

  • 4. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
    Budd SJ, Thompson H, Hartnett ME.
    Arch Ophthalmol; 2010 Aug 05; 128(8):1014-21. PubMed ID: 20697002
    [Abstract] [Full Text] [Related]

  • 5. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H, Fukushima Y, Maruyama K, Hirashima M, Nishida K, Nishikawa S, Uemura A.
    Invest Ophthalmol Vis Sci; 2013 Jun 12; 54(6):4102-8. PubMed ID: 23696610
    [Abstract] [Full Text] [Related]

  • 6. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
    Zhang W, Yokota H, Xu Z, Narayanan SP, Yancey L, Yoshida A, Marcus DM, Caldwell RW, Caldwell RB, Brooks SE.
    Invest Ophthalmol Vis Sci; 2011 Aug 11; 52(9):6384-95. PubMed ID: 21705685
    [Abstract] [Full Text] [Related]

  • 7. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M, Ristori C, Cammalleri M, Bagnoli P.
    Invest Ophthalmol Vis Sci; 2009 Aug 11; 50(8):3596-606. PubMed ID: 19324858
    [Abstract] [Full Text] [Related]

  • 8. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
    Cheng G, He T, Xing Y.
    Eye (Lond); 2016 Jun 11; 30(6):877-87. PubMed ID: 26987588
    [Abstract] [Full Text] [Related]

  • 9. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J, Afzal A, Pan H, Gallego E, Li N, Li Calzi S, Caballero S, Spoerri PE, Shaw LC, Grant MB.
    Invest Ophthalmol Vis Sci; 2006 Jul 11; 47(7):3151-5. PubMed ID: 16799062
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of hypoxia-induced retinal neovascularization in mice with short hairpin RNA targeting Rac1, possibly via blockading redox signaling.
    Zhang XZ, Huang X, Qiao JH, Zhang JJ, Zhang MX.
    Exp Eye Res; 2011 Jun 11; 92(6):473-81. PubMed ID: 21414312
    [Abstract] [Full Text] [Related]

  • 11. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
    Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE.
    Invest Ophthalmol Vis Sci; 2009 Mar 11; 50(3):1329-35. PubMed ID: 18952918
    [Abstract] [Full Text] [Related]

  • 12. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Liu N, Chen L, Cai N.
    Int J Clin Exp Pathol; 2015 Mar 11; 8(5):4990-8. PubMed ID: 26191192
    [Abstract] [Full Text] [Related]

  • 13. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
    Scott A, Powner MB, Fruttiger M.
    Exp Eye Res; 2014 Mar 11; 120():55-60. PubMed ID: 24418725
    [Abstract] [Full Text] [Related]

  • 14. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y.
    Curr Eye Res; 2008 Oct 11; 33(10):892-902. PubMed ID: 18853324
    [Abstract] [Full Text] [Related]

  • 15. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F, Bai Y, Yu W, Han N, Huang L, Zhao M, Zhou A, Zhao M, Li X.
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep 11; 251(9):2131-9. PubMed ID: 23740520
    [Abstract] [Full Text] [Related]

  • 16. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW, Jun HO, Kwon E, Yun JW, Kim JH, Park YJ, Kang BC, Kim JH.
    Vascul Pharmacol; 2017 Mar 11; 90():19-26. PubMed ID: 27473515
    [Abstract] [Full Text] [Related]

  • 17. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
    van Wijngaarden P, Brereton HM, Gibbins IL, Coster DJ, Williams KA.
    Exp Eye Res; 2007 Oct 11; 85(4):508-17. PubMed ID: 17692314
    [Abstract] [Full Text] [Related]

  • 18. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
    He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR.
    Invest Ophthalmol Vis Sci; 2005 Dec 11; 46(12):4772-9. PubMed ID: 16303978
    [Abstract] [Full Text] [Related]

  • 19. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
    Chu ZJ, Dou GR, Wang YS, Qu XJ, Zhang Y.
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug 11; 251(8):1937-43. PubMed ID: 23740517
    [Abstract] [Full Text] [Related]

  • 20. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases.
    Umeda N, Ozaki H, Hayashi H, Oshima K.
    Am J Ophthalmol; 2004 Aug 11; 138(2):270-9. PubMed ID: 15289137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.